Last reviewed · How we verify
Intravenous Sedatives
Intravenous sedatives depress the central nervous system to produce sedation, anxiolysis, and unconsciousness for medical procedures and critical care.
Intravenous sedatives depress the central nervous system to produce sedation, anxiolysis, and unconsciousness for medical procedures and critical care. Used for Induction and maintenance of general anesthesia, Procedural sedation and anxiolysis, Intensive care unit sedation.
At a glance
| Generic name | Intravenous Sedatives |
|---|---|
| Also known as | Propofol or Dexmedetomidine |
| Sponsor | University of Florida |
| Drug class | Central nervous system depressant / Sedative-hypnotic |
| Target | GABA-A receptor (primary for most IV sedatives) |
| Modality | Small molecule |
| Therapeutic area | Anesthesia / Critical Care / Procedural Sedation |
| Phase | FDA-approved |
Mechanism of action
IV sedatives work by enhancing inhibitory neurotransmission in the brain, primarily through GABA-A receptor agonism (for benzodiazepines and propofol) or other CNS depressant pathways. This results in reduced consciousness, muscle relaxation, and amnesia, making them essential for anesthesia induction, procedural sedation, and ICU sedation management.
Approved indications
- Induction and maintenance of general anesthesia
- Procedural sedation and anxiolysis
- Intensive care unit sedation
- Preoperative anxiolysis
Common side effects
- Respiratory depression
- Hypotension
- Bradycardia
- Injection site pain
- Apnea
- Paradoxical agitation
Key clinical trials
- Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery (PHASE1)
- Can Nitrous Oxide (Laughing Gas) be Used as a Sedative for GI Endoscopy Procedures? (PHASE4)
- Randomized Trial of Sedative Choice for Intubation (PHASE4)
- Comparison of Two Sedative Agents in Terms of Controlled Hypotension (NA)
- The Effect of Music on Anxiety Levels and Sleep Quality in Patients Who Have a Myocardial Infarction (NA)
- A Comparison of Remimazolam Besylate and Propofol Sedation in Patients Undergoing Colonoscopic Polypectomy (PHASE4)
- Reduction of Muscle Catabolism Through Brain Activation in Burn Patients (NA)
- Comparison of C-Reactive Protein Levels in Traumatic Brain Injury Patients Undergoing Craniotomy With and Without Dexmedetomidine (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intravenous Sedatives CI brief — competitive landscape report
- Intravenous Sedatives updates RSS · CI watch RSS
- University of Florida portfolio CI